B cells in multiple sclerosis
- 1 January 2004
- journal article
- review article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 9 (1-3) , 786-96
- https://doi.org/10.2741/1278
Abstract
The most common laboratory abnormality in multiple sclerosis (MS) is an increased amount of cerebrospinal fluid IgG and the presence of oligoclonal bands. Despite studies of the humoral response that suggest the involvement of an infectious agent or autoantigen in disease, the major targets of the oligoclonal response are still unknown. Identification of these targets will reveal valuable insights into the cause and pathogenesis of MS and is likely to lead to effective treatment.Keywords
This publication has 97 references indexed in Scilit:
- Antibodies against oligodendrocytes in serum and CSF in multiple sclerosis and other neurological diseases: 125I-protein A studiesActa Neurologica Scandinavica, 2009
- Tissue Distribution and Variant Characterization of Human Herpesvirus (HHV)–6: Increased Prevalence of HHV‐6A in Patients with Multiple SclerosisThe Journal of Infectious Diseases, 2000
- Multiple sclerosis – in need of a critical reappraisalMedical Hypotheses, 2000
- The Instructive Role of Innate Immunity in the Acquired Immune ResponseScience, 1996
- Demyelination following Transfer of Human Lymphocytes into Mice with Severe Combined ImmunodeficiencyPathobiology, 1996
- The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosisJournal of Neuroimmunology, 1994
- Anti‐myelin basic protein and anti‐proteolipid protein specific forms of multiple sclerosisAnnals of Neurology, 1994
- Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particlesResearch in Virology, 1989
- Lipid/myelin basic protein multilayersJournal of Molecular Biology, 1984
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983